Healthcare: Air Liquide Reinforces Its Presence in Europe with the Acquisition of Medidis in the Netherlands

PARIS–(BUSINESS WIRE)–Regulatory News:

Air Liquide (Paris:AI) is pursuing the development of its Healthcare
business in Europe with the acquisition of Medidis, a major player in
the Netherlands for the treatment of respiratory diseases at home and
the production and supply of medical oxygen. With this acquisition, Air
Liquide, leader in home healthcare in Europe and present in the home
healthcare market in the Netherlands for more than 20 years, strengthens
its position in a growing market.

Medidis is a nationwide player that provides home healthcare support for
patients suffering from respiratory failure and sleep apnea.
Medidis supplies medical oxygen to patients being treated at home as
well as those receiving care in assisted living facilities and to
healthcare professionals who work outside the hospital setting. It also
operates a medical oxygen production facility.

Present for more than 25 years in the Dutch market, Medidis
employs more than 70 people and generated revenue of
approximately 11 million euros in 2017.
This acquisition both
reinforces and diversifies Air Liquide’s existing healthcare offering
and allows the Group to directly serve more than 26,000 additional
patients in this country.
Air Liquide will work with the existing
teams to pursue the development of these businesses.

Already present in the Netherlands, Air Liquide will be able to leverage
the complementarity of Medidis in both geographic and therapeutic
. Concerning home healthcare, this acquisition will reinforce
the Group’s position in the support of patients who suffer from
respiratory failure. Moreover, it will increase its customer base with
healthcare professionals who work outside the hospital (such as medical
homes or ambulances). Air Liquide will also benefit from Medidis’
established relationships with doctors, hospitals, and insurers in new
regions and from an increased production capacity, which will allow the
Group to further develop healthcare activities in the Netherlands.

François Jackow , member of the Air Liquide Executive Committee,
supervising Healthcare activities stated: “This acquisition gives
Air Liquide an added dimension in the Dutch market. We are delighted to
welcome the Medidis teams, recognized for their expertise in the
treatment of respiratory diseases and their knowledge of the Dutch
market, both at home and the growing market for the supply of medical
oxygen outside the hospital. Air Liquide thus continues its momentum in
terms of strengthening its positions in Europe, which is key to our
strategy of developing the Healthcare business.”

Air Liquide Healthcare
Supplies medical
gases, home healthcare services, hygiene products, medical equipment and
specialty ingredients
. In 2018, it served over 15,000 hospitals
and clinics
and more than 1.6 million patients at home
throughout the world. The Group’s Healthcare business reached €3,486
million in revenues in 2018
, with the support of its 16,500

The Home Healthcare Business
Liquide, European leader in home healthcare, provides home
healthcare services in compliance with medical prescription for patients
suffering from chronic diseases such as COPD (Chronic Obstructive
Pulmonary Disease), sleep apnea and diabetes. These home healthcare
services are being developed in addition to hospital care, enabling
patients to enjoy better quality of life and local authorities to reduce
costs. Home healthcare represents 45% of Air Liquide’s revenue in
Healthcare in 2018

A world leader in gases, technologies and services for Industry and
Health, Air Liquide is present in 80 countries with approximately 66,000
employees and serves more than 3.6 million customers and patients.
Oxygen, nitrogen and hydrogen are essential small molecules for life,
matter and energy. They embody Air Liquide’s scientific territory and
have been at the core of the company’s activities since its creation in

Air Liquide’s ambition is to be a leader in its industry, deliver long
term performance and contribute to sustainability. The company’s
customer-centric transformation strategy aims at profitable growth over
the long term. It relies on operational excellence, selective
investments, open innovation and a network organization implemented by
the Group worldwide. Through the commitment and inventiveness of its
people, Air Liquide leverages energy and environment transition, changes
in healthcare and digitization, and delivers greater value to all its

Air Liquide’s revenue amounted to 21 billion euros in 2018 and its
solutions that protect life and the environment represented more than
40% of sales. Air Liquide is listed on the Euronext Paris stock exchange
(compartment A) and belongs to the CAC 40, EURO STOXX 50 and FTSE4Good
us on Twitter @airliquidegroup


Corporate Communications
(0)1 40 62 58 49

Investor Relations
Paris – France
+33 (0)1 40 62 50 87
+1 610 263 8277

Air Liquide Healthcare Communications
Coralie Gazzeri
(0)1 49 69 45 40

Thank you for donating to

We could not provide the Dutch News service, and keep it free of charge, without the generous support of our readers. Your donations allow us to report on issues you tell us matter, and provide you with a summary of the most important Dutch news each day.

Make a donation